IMVT - Immunovant, Inc.
IEX Last Trade
25.475
-0.530 -2.080%
Share volume: 26,336
Last Updated: Fri 27 Dec 2024 02:30:20 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.33%
PREVIOUS CLOSE
CHG
CHG%
$26.00
-0.53
-2.04%
View ratios
| Fiscal Date | |
|---|---|
| Fiscal Quarter | |
| Report Date | |
| Total revenue | |
| Cost of revenue | |
| Gross profit | |
| Operating expenses | |
| Selling general and admin | |
| Research and development | |
| Total expenses | |
| Operating income | |
| Ebit | |
| Pretax income | |
| Income tax | |
| Net income basic | |
| Net income |